10.1002/ejoc.201801565
European Journal of Organic Chemistry
FULL PAPER
= 7.2 Hz, 3H). 13C NMR (150 MHz, CDCl3) δ = 167.80, 166.31, 164.77 (q,
JC-F = 3.0 Hz, C-SCF3), 162.90, 151.52, 149.12, 128.84, 128.28 (q, JC-F
=306.3 Hz, SCF3), 122.68, 121.84, 111.64, 110.73, 62.13, 55.99, 55.83,
22.39, 13.79. 19F NMR (376 MHz, CDCl3) δ = -41.13. HRMS (ESI) m/z:
Calcd for C17H17F3N2O4S: 403.0934 [M+H]+, Found: 403.0938.
130.60, 128.19 (q, JC-F = 306.5 Hz, SCF3), 128.57, 128.55, 123.77, 70.10,
22.43, 21.25.19F NMR (376 MHz, CDCl3) δ = -41.09. HRMS (ESI) m/z:
Calcd for C16H15F3N2O2S: 357.0879 [M+H]+, Found: 357.0877.
Methyl
4-(4-bromophenyl)-6-methyl-2-
((trifluoromethyl)thio)pyrimidine-5-carboxylate (3u). White solid (60.0
mg, 74%); m.p.:118-120 °C. 1H NMR (600 MHz, CDCl3) δ = 7.61–7.58 (m,
2H), 7.56–7.52 (m, 2H), 3.76 (s, 3H), 2.57 (s, 3H). 13C NMR (150 MHz,
CDCl3) δ = 167.63, 167.03, 165.46 (q, JC-F = 3.0 Hz, C-SCF3), 162.75,
135.28, 131.99, 129.95, 128.09 (q, JC-F =306.3 Hz, SCF3), 125.76,
122.72, 52.92, 22.60.19F NMR (376 MHz, CDCl3) δ = -41.13. HRMS (ESI)
m/z: Calcd for C14H10BrF3N2O2S: 406.9671 [M+H]+, Found: 406.9675.
Ethyl
4-(3,4-dichlorophenyl)-6-methyl-2-
((trifluoromethyl)thio)pyrimidine-5-carboxylate (3o). Colourless oil
(55.8 mg, 68%); 1H NMR (400 MHz, CDCl3) δ = 7.78 (dd, J = 1.6, 0.8 Hz,
1H), 7.55–7.51 (m, 2H), 4.29 (q, J = 7.2 Hz, 2H), 2.59 (s, 3H), 1.20 (t, J =
7.2 Hz, 3H). 13C NMR (150 MHz, CDCl3) δ = 167.17, 166.76, 165.44 (q,
JC-F = 3.3 Hz, C-SCF3), 161.35, 136.19, 135.35, 133.09, 130.69, 130.41,
127.70, 127.68, 128.05 (q, JC-F =306.5 Hz, SCF3), 123.18, 62.44, 22.60,
13.75. 19F NMR (376 MHz, CDCl3) δ = -41.14. HRMS (ESI) m/z: Calcd
for C15H11Cl2F3N2O2S: 410.9943 [M+H]+, Found: 410.9945.
Tert-butyl
4-methyl-6-phenyl-2-((trifluoromethyl)thio)pyrimidine-5-
carboxylate (3v). Colourless oil (63.6 mg, 86%); 1H NMR (600 MHz,
CDCl3) δ = 7.71–7.68 (m, 2H), 7.51–7.47 (m, 1H), 7.47–7.43 (m, 2H),
2.59 (s, 3H), 1.38 (s, 9H).13C NMR (150 MHz, CDCl3) δ = 166.21 (d, J =
11.0 Hz), 164.47 (q, J = 3.0 Hz, C-SCF3), 163.70, 136.62, 130.51, 128.69,
128.47, 128.24 (q, J = 306.3 Hz, SCF3), 124.74, 83.63, 27.64, 22.41. 19F
NMR (376 MHz, CDCl3) δ ppm = -41.09. HRMS (ESI) m/z: Calcd for
C17H17F3N2O2S: 371.1036 [M+H]+, Found: 371.1039.
Ethyl 4-methyl-6-(thiophen-2-yl)-2-((trifluoromethyl)thio)pyrimidine-
5-carboxylate (3p). Colourless oil (43.2 mg, 62%); 1H NMR (600 MHz,
CDCl3) δ = 7.93 (dd, J = 3.0, 1.2 Hz, 1H), 7.47 (dd, J = 5.4, 1.2 Hz, 1H),
7.37 (dd, J = 4.8, 3.0 Hz, 1H), 4.36 (q, J = 7.2 Hz, 2H), 2.52 (s, 3H), 1.27
(t, J = 7.2 Hz, 3H).13C NMR (150 MHz, CDCl3) δ = 167.60, 166.19,
164.92 (q, J = 3.2 Hz, C-SCF3), 157.40, 137.74, 129.13, 128.24 (q, J =
306.3 Hz, SCF3), 127.37, 126.46, 122.16, 62.36, 22.31, 13.82. 19F NMR
Ethyl
4-isopropyl-6-(p-tolyl)-2-((trifluoromethyl)thio)pyrimidine-5-
carboxylate (3w). Colourless oil (62.2 mg, 81%); 1H NMR (600 MHz,
CDCl3) δ = 7.57 (d, J = 7.8 Hz, 2H), 7.24 (d, J = 9.0 Hz, 2H), 4.22 (q, J =
7.2 Hz, 2H), 3.19–3.12 (m, 1H), 2.40 (s, 3H), 1.30 (d, J = 6.6 Hz, 6H),
1.13 (t, J = 7.2 Hz, 3H).13C NMR (150 MHz, CDCl3) δ = 174.25, 167.56,
165.34 (q, J = 3.2 Hz, C-SCF3), 164.12, 141.00, 133.87, 129.31, 128.40,
128.35 (q, J = 306.2 Hz, SCF3), 122.40, 62.03, 33.35, 21.55, 21.36,
13.65 19F NMR (376 MHz, CDCl3) δ = -41.09. HRMS (ESI) m/z: Calcd for
C18H19F3N2O2S: 385.1192 [M+H]+, Found: 385.1195.
(376 MHz, CDCl3)
δ = -41.15. HRMS (ESI) m/z: Calcd for
C13H11F3N2O2S2: 349.0287 [M+H]+, Found: 349.0286.
Ethyl
4-(benzo[d][1,3]dioxol-4-yl)-6-methyl-2-
((trifluoromethyl)thio)pyrimidine-5-carboxylate (3q). Colourless oil
1
(48.6 mg, 63%); H NMR (400 MHz, CDCl3) δ = 7.24–7.19 (m, 2H), 6.86
(d, J = 8.0 Hz, 1H), 6.03 (s, 2H), 4.28 (q, J = 7.2 Hz, 2H), 2.55 (s, 3H),
1.21 (t, J = 7.2 Hz, 3H).13C NMR (150 MHz, CDCl3) δ= 167.53, 166.44,
164.85 (q, J = 3.3 Hz, C-SCF3), 162.96, 150.05, 148.18, 130.36, 128.20
(q, J = 306.3 Hz, SCF3), 123.48, 122.81, 108.87, 108.35, 101.67, 62.15,
22.46, 13.78. 19F NMR (376 MHz, CDCl3) δ = -41.10. HRMS (ESI) m/z:
Calcd for C16H13F3N2O4S: 387.0621 [M+H]+, Found: 387.0625.
6-methoxy-4-phenyl-2-((trifluoromethyl)thio)quinoline (5a). Yellow
solid (57.6 mg, 86%); m.p.: 95-97 °C. 1H NMR (400 MHz, CDCl3) δ =
8.07 (d, J = 9.2 Hz, 1H), 7.59–7.49 (m, 6H), 7.42 (dd, J = 9.2, 2.8 Hz, 1H),
7.17 (d, J = 2.8 Hz, 1H), 3.79 (s, 3H).13C NMR (150 MHz, CDCl3) δ =
158.88, 148.91, 145.74 (q, JC-F = 2.4 Hz, C-SCF3), 145.18, 137.23,
131.36, 19.64 (q, JC-F = 306.9 Hz, SCF3), 129.21, 128.85, 128.83, 127.23,
124.99 (d, JC-F = 1.8 Hz, C-CSCF3), 122.87, 103.62, 55.49. 19F NMR (376
MHz, CDCl3) δ = -39.99. HRMS (ESI) m/z: Calcd for C17H12F3NOS:
336.0664 [M+H]+, Found: 336.0666.
Ethyl
4-methyl-6-(naphthalen-2-yl)-2-
((trifluoromethyl)thio)pyrimidine-5-carboxylate (3r). Colourless oil
1
(54.8 mg, 70%); H NMR (600 MHz, CDCl3) δ = 8.19 (s, 1H), 7.93–7.86
(m, 3H), 7.77 (dd, J = 8.4, 1.8 Hz, 1H), 7.58–7.51 (m, 2H), 4.21 (q, J =
7.2 Hz, 2H), 2.62 (s, 3H), 1.04 (t, J = 7.2 Hz, 3H). 13C NMR (150 MHz,
CDCl3) δ = 167.44, 166.72, 165.13 (q, JC-F = 2.9 Hz, C-SCF3), 163.93,
133.81, 132.80, 129.02, 128.83, 128.48, 127.72, 127.65, 128.22 (q, JC-F
= 306.5 Hz, SCF3), 126.74, 125.17, 123.48, 62.15, 22.57, 13.66. 19F
NMR (376 MHz, CDCl3) δ = -41.03. HRMS (ESI) m/z: Calcd for
C19H15F3N2O2S: 393.0879 [M+H]+, Found: 393.0877.
7-chloro-4-phenyl-2-((trifluoromethyl)thio)quinoline (5b). Yellow solid
1
(54.2 mg, 80%); m.p.: 287-289 °C. H NMR (600 MHz, CDCl3) δ = 8.08
(dd, J = 9.0, 3.2 Hz, 1H), 7.86 (t, J = 2.4 Hz, 1H), 7.69 (dt, J = 9.0, 2.4 Hz,
1H), 7.58–7.54 (m, 3H), 7.52 (d, J = 3.0 Hz, 1H), 7.49–7.46 (m, 2H). 13
C
NMR (150 MHz, CDCl3) δ = 150.07 (q, JC-F = 2.4 Hz, C-SCF3), 149.56,
147.23, 136.26, 133.75, 131.36, 131.26, 139.27 (q, JC-F = 307.1 Hz,
SCF3), 129.33, 129.23, 128.96, 126.51, 124.74, 123.89 (d, JC-F = 2.1 Hz,
C-SCF3, it should be quartet, but only doublet was observed.). 19F NMR
(376 MHz, CDCl3) δ = -39.55. HRMS (ESI) m/z: Calcd for C16H9ClF3NS:
340.0169 [M+H]+, Found: 340.0166.
Ethyl
4-methyl-6-(naphthalen-1-yl)-2-
((trifluoromethyl)thio)pyrimidine-5-carboxylate (3s). Colourless oil
(41.6 mg, 53%); 1H NMR (600 MHz, CDCl3) δ = 7.94 (d, J = 8.4 Hz, 1H),
7.90–7.88 (m, 1H), 7.73 (d, J = 8.1 Hz, 1H), 7.53–7.47 (m, 3H), 7.43 (dd,
J = 6.6, 1.2 Hz, 1H), 3.81 (q, J = 7.2 Hz, 2H), 2.68 (s, 3H), 0.56 (t, J = 7.2
Hz, 3H). 13C NMR (150 MHz, CDCl3) δ = 167.31, 166.20, 165.77, 165.24
(q, J = 3 Hz, C-SCF3), 134.55, 133.46, 130.51, 130.19, 128.29, 128.13 (q,
J = 306.5 Hz, SCF3), 126.89, 126.37, 125.50, 124.99, 124.80, 61.60,
22.95, 13.07. 19F NMR (376 MHz, CDCl3) δ = -41.03. HRMS (ESI) m/z:
Calcd for C19H15F3N2O2S: 393.0879 [M+H]+, Found: 393.0881.
6-ethyl-4-(p-tolyl)-2-((trifluoromethyl)thio)quinoline (5c). Yellow solid
(53.4 mg, 77%); 1H NMR (600 MHz, CDCl3) δ = 8.08 (d, J = 8.4 Hz, 1H),
7.70 (s, 1H), 7.63 (dd, J = 9.0, 2.4 Hz, 1H), 7.50 (s, 1H), 7.42–7.39 (m,
2H), 7.36 (d, J = 7.8 Hz, 2H), 2.77 (q, J = 7.2 Hz, 2H), 2.48 (s, 3H), 1.25
(t, J = 7.8 Hz, 3H). 13C NMR (150 MHz, CDCl3) δ = 149.89, 148.04 (q, JC-
Isopropyl
4-methyl-6-phenyl-2-((trifluoromethyl)thio)pyrimidine-5-
= 2.6 Hz, C-SCF3), 147.81, 144.11, 138.85, 134.23, 131.45, 129.93 (q,
F
carboxylate (3t). Colourless oil (49.2 mg, 69%); 1H NMR (600 MHz,
CDCl3) δ = 7.68–7.66 (m, 2H), 7.50–7.42 (m, 3H), 5.14–5.07 (m, 1H),
2.58 (s, 3H), 1.10 (d, J = 6.0 Hz, 6H).13C NMR (150 MHz, CDCl3) δ =
166.73, 166.42, 164.92 (q, JC-F = 3.0 Hz, C-SCF3), 163.96, 136.53,
JC-F = 108.5 Hz, SCF3), 129.63, 129.43, 129.37, 126.04, 124.02 (d, JC-F =
2.3 Hz, C-SCF3), 123.48, 29.16, 21.31, 15.45. 19F NMR (376 MHz,
CDCl3) δ = -39.77. HRMS (ESI) m/z: Calcd for C19H16F3NS: 348.1028
[M+H]+, Found: 348.1030.
This article is protected by copyright. All rights reserved.